Brian Cuban to Represent CBIH in DEA Hearings on Marijuana Reclassification
CBIH has announced that Brian Cuban, Esq., a notable attorney, best-selling author, and mental health advocate, has joined their Reclassification Team. Cuban will represent CBIH at the DEA hearings on marijuana rescheduling. He brings a unique blend of personal recovery experience and professional advocacy. Cuban, a graduate of Penn State University and The University of Pittsburgh School of Law, has been a vocal champion for individuals facing addiction and mental health challenges. His notable works include 'The Addicted Lawyer' and 'Body Brokers.'
Rosangel Andrades, CBIH R&D Director, praised Cuban's addition, emphasizing the company's commitment to reclassification efforts. Cuban's extensive legal background, with over two decades of experience, makes him a valuable asset in constructing evidence-based arguments for rescheduling marijuana. The reclassification aims to address marijuana's current Schedule I designation under the Controlled Substances Act (CSA), which contradicts modern scientific understanding.
CBIH is dedicated to presenting robust scientific evidence on marijuana's medical benefits, advocating for its reclassification to improve access to treatments for chronic pain, cancer, epilepsy, PTSD, anxiety, and more.
CBIH ha annunciato che Brian Cuban, Esq., un avvocato di rilievo, autore di best-seller e sostenitore della salute mentale, è entrato a far parte del loro Team di Riconfigurazione. Cuban rappresenterà CBIH alle audizioni DEA sulla riclassificazione della marijuana. Porta con sé un'esperienza unica di recupero personale e advocacy professionale. Cuban, laureato alla Penn State University e alla University of Pittsburgh School of Law, è un sostenitore attivo per le persone che affrontano la dipendenza e le sfide della salute mentale. Le sue opere più significative includono 'The Addicted Lawyer' e 'Body Brokers.'
Rosangel Andrades, Direttore R&D di CBIH, ha elogiato l'aggiunta di Cuban, enfatizzando l'impegno dell'azienda negli sforzi di riclassificazione. L'ampio background legale di Cuban, con oltre vent'anni di esperienza, lo rende una risorsa preziosa nella costruzione di argomentazioni basate su evidenze per la riclassificazione della marijuana. L'obiettivo della riclassificazione è affrontare l'attuale designazione di Schedule I della marijuana ai sensi del Controlled Substances Act (CSA), che contraddice la comprensione scientifica moderna.
CBIH è dedicata a presentare solide evidenze scientifiche sui benefici medici della marijuana, sostenendo la sua riclassificazione per migliorare l'accesso ai trattamenti per il dolore cronico, il cancro, l'epilessia, il PTSD, l'ansia e molto altro.
CBIH ha anunciado que Brian Cuban, Esq., un destacado abogado, autor de best-sellers y defensor de la salud mental, se ha unido a su Equipo de Reclasificación. Cuban representará a CBIH en las audiencias de la DEA sobre la reclasificación de la marihuana. Aporta una mezcla única de experiencia personal en recuperación y defensa profesional. Cuban, graduado de la Penn State University y de la Facultad de Derecho de la Universidad de Pittsburgh, ha sido un defensor vocal de las personas que enfrentan adicciones y desafíos de salud mental. Sus obras notables incluyen 'The Addicted Lawyer' y 'Body Brokers.'
Rosangel Andrades, Directora de I+D de CBIH, elogió la incorporación de Cuban, enfatizando el compromiso de la empresa con los esfuerzos de reclasificación. El extenso background legal de Cuban, con más de dos décadas de experiencia, lo convierte en un recurso valioso para construir argumentos basados en evidencia para la reclasificación de la marihuana. El objetivo de la reclasificación es abordar la actual designación de la marihuana como Schedule I bajo la Ley de Sustancias Controladas (CSA), que contradice la comprensión científica moderna.
CBIH se dedica a presentar pruebas científicas sólidas sobre los beneficios médicos de la marihuana, abogando por su reclasificación para mejorar el acceso a tratamientos para el dolor crónico, el cáncer, la epilepsia, el PTSD, la ansiedad y más.
CBIH는 유명한 변호사이자 베스트셀러 작가, 정신 건강 옹호자인 Brian Cuban, Esq.가 재분류 팀에 합류했다고 발표했습니다. Cuban은 마리화나 재조정에 관한 DEA 청문회에서 CBIH를 대표할 것입니다. 그는 개인 회복 경험과 전문적 옹호를 독특하게 결합한 인물입니다. Penn State University와 Pittsburgh 대학교 법학원을 졸업한 Cuban은 중독과 정신 건강 문제에 직면한 개인들의 강력한 옹호자가 되어 왔습니다. 그의 주목할 만한 작품으로는 'The Addicted Lawyer'와 'Body Brokers'가 있습니다.
CBIH 연구개발 총괄인 Rosangel Andrades는 Cuban의 합류를 칭찬하며 회사의 재분류 노력에 대한 헌신을 강조했습니다. 20년 이상의 경력을 가진 Cuban의 광범위한 법적 배경은 마리화나 재조정을 위한 근거 기반 주장을 구성하는 데 귀중한 자산이 됩니다. 재분류의 목표는 마리화나의 현재 Schedule I 지정이 현대 과학적 이해와 모순되기 때문에 이를 해결하는 것입니다.
CBIH는 마리화나의 의학적 혜택에 대한 강력한 과학적 증거를 제시하고, 만성 통증, 암, 간질, PTSD, 불안 등 치료에 대한 접근성을 개선하기 위해 재분류를 옹호하는데 전념하고 있습니다.
CBIH a annoncé que Brian Cuban, Esq., un avocat de renom, auteur à succès et défenseur de la santé mentale, a rejoint leur Équipe de Reclassement. Cuban représentera CBIH lors des audiences de la DEA sur la reclassification de la marijuana. Il apporte un mélange unique d'expérience de rétablissement personnel et d'engagement professionnel. Cuban, diplômé de la Penn State University et de la Fac de Droit de l’Université de Pittsburgh, est un champion vocal pour les personnes confrontées à la dépendance et aux défis en matière de santé mentale. Ses œuvres notables comprennent 'The Addicted Lawyer' et 'Body Brokers.'
Rosangel Andrades, Directrice R&D de CBIH, a loué l'ajout de Cuban, en soulignant l'engagement de l'entreprise envers les efforts de reclassification. L'expérience juridique étendue de Cuban, avec plus de vingt ans d'expérience, fait de lui un atout précieux pour construire des arguments basés sur des preuves en faveur de la reclassification de la marijuana. L'objectif de la reclassification est de traiter l'actuelle désignation de la marijuana en tant que Schedule I au sens de la Controlled Substances Act (CSA), ce qui contredit la compréhension scientifique moderne.
CBIH s'engage à présenter des preuves scientifiques solides sur les bienfaits médicaux de la marijuana, plaidant pour sa reclassification afin d'améliorer l'accès aux traitements pour la douleur chronique, le cancer, l'épilepsie, le PTSD, l'anxiété, et plus encore.
CBIH hat angekündigt, dass Brian Cuban, Esq., ein namhafter Anwalt, Bestsellerautor und Unterstützer der psychischen Gesundheit, ihrem Reklassifizierungsteam beigetreten ist. Cuban wird CBIH bei den DEA-Anhörungen zur Neubewertung von Marihuana vertreten. Er bringt eine einzigartige Mischung aus persönlicher Genesungserfahrung und beruflichem Engagement mit. Cuban, Absolvent der Penn State University und der University of Pittsburgh School of Law, hat sich lautstark für Menschen eingesetzt, die mit Sucht und psychischen Gesundheitsproblemen kämpfen. Zu seinen bemerkenswerten Werken gehören 'The Addicted Lawyer' und 'Body Brokers.'
Rosangel Andrades, R&D-Direktorin von CBIH, lobte Cubans Hinzukommen und betonte das Engagement des Unternehmens für die Reklassifizierungsanstrengungen. Cubans umfangreicher juristischer Hintergrund, mit mehr als zwei Jahrzehnten Erfahrung, macht ihn zu einem wertvollen Asset bei der Konstruktion evidenzbasierter Argumente für die Neubewertung von Marihuana. Die Reklassifizierung zielt darauf ab, die aktuelle Einstufung von Marihuana als Schedule I gemäß dem Gesetz über kontrollierte Substanzen (CSA) zu überprüfen, was der modernen wissenschaftlichen Erkenntnis widerspricht.
CBIH hat sich der Präsentation robuster wissenschaftlicher Beweise für die medizinischen Vorteile von Marihuana verschrieben und setzt sich für dessen Reklassifizierung ein, um den Zugang zu Behandlungen für chronische Schmerzen, Krebs, Epilepsie, PTSD, Angstzustände und mehr zu verbessern.
- Brian Cuban's addition to the team enhances CBIH's advocacy efforts.
- Cuban's extensive legal experience strengthens CBIH's case for rescheduling marijuana.
- The reclassification effort aims to modernize policies and improve public health.
- None.
HOUSTON, Jan. 13, 2025 (GLOBE NEWSWIRE) -- CBIH is proud to announce that Brian Cuban, Esq., a distinguished attorney, best-selling author, mental health advocate, and esteemed member of our Advisory Board, has officially joined the Reclassification Team. Mr. Cuban will play a crucial role in representing CBIH at the upcoming DEA hearings on marijuana rescheduling.
Brian Cuban, the younger brother of entrepreneur Mark Cuban, brings a unique combination of personal recovery experience and professional advocacy to the effort. A graduate of Penn State University and The University of Pittsburgh School of Law, Mr. Cuban has been a vocal champion for individuals battling addiction, mental health challenges, and societal stigma.
Mr. Cuban has established himself as a thought leader in the mental health space, authoring the best-selling book The Addicted Lawyer: Tales of The Bar, Booze, Blow & Redemption and captivating audiences across North America as a keynote speaker. His work has been featured in esteemed publications such as The New York Times, CNN.com, and The Huffington Post. His most recent release, Body Brokers, sheds light on the dark and exploitative practices within the addiction recovery industry, exposing unethical behaviors that prey on vulnerable individuals seeking treatment.
“Mr. Brian Cuban’s addition to our team reinforces our commitment to advancing reclassification,” said Rosangel Andrades, CBIH R&D Director. “I am incredibly proud to be part of a company that spares no effort or resources in taking our projects to the next level. This effort is not just about science, it’s about making a meaningful difference in the quality of life for thousands of patients.”
In addition to his advocacy, Mr. Cuban’s extensive legal background makes him a key asset in CBIH’s reclassification efforts. With over two decades of legal experience, he possesses a profound understanding of regulatory frameworks and the nuanced intersections of public policy, healthcare, and legal reform. His skill in constructing evidence-based, persuasive arguments will fortify CBIH’s case for rescheduling marijuana, helping to dismantle outdated policies that hinder scientific advancement and access to critical treatments.
The reclassification of marijuana under the Controlled Substances Act (CSA) seeks to address its current designation as a Schedule I substance, a category reserved for drugs with high abuse potential, no accepted medical use, and a lack of safety under medical supervision. This classification contradicts modern scientific and medical understanding. CBIH is committed to presenting robust scientific evidence highlighting marijuana’s proven medical benefits for conditions such as chronic pain, cancer, epilepsy, PTSD, anxiety, and more. The push for reclassification centers on advancing science, modernizing policy, and improving public health to ensure greater access to evidence-based therapies.
FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements. The words "believe," "expect," "should," "intend," "estimate," "projects," variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. These forward-looking statements are based upon the Company's current expectations and are subject to a number of risks, uncertainties, and assumptions. The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise. Among the important factors that could cause actual results to differ significantly from those expressed or implied by such forward-looking statements are risks that are detailed in the Company's filings, which are on file at www.OTCmarkets.com.
For more information contact us at:
(214) 733-0868
ir@cbih.net
Dante Picazo
CEO - CBIH
Website: www.cbih.net
X: www.twitter.com/cbihstock
Instagram: www.instagram.com/CBIHSTOCK
FAQ
What role will Brian Cuban play in CBIH's DEA hearings?
What is the significance of marijuana reclassification for CBIH?
Why is Brian Cuban's involvement important for CBIH?
What medical benefits of marijuana is CBIH highlighting?
How does CBIH plan to support its case for marijuana reclassification?
What is the current classification of marijuana under the CSA?
